APDN - Applied DNA Sciences, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
2.35
+0.02 (+0.86%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close2.33
Open2.36
Bid1.41 x 700
Ask2.50 x 300
Day's Range2.19 - 2.49
52 Week Range0.90 - 3.45
Volume71,659
Avg. Volume111,661
Market Cap64.34M
Beta-2.22
PE Ratio (TTM)-4.84
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube6 days ago

    ETFs with exposure to Applied DNA Sciences, Inc. : October 13, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Applied DNA Sciences, Inc. Here are 5 ETFs with the largest exposure to APDN-US. Comparing the performance and risk of Applied DNA Sciences, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)

  • Capital Cubelast month

    ETFs with exposure to Applied DNA Sciences, Inc. : September 12, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Applied DNA Sciences, Inc. Here are 5 ETFs with the largest exposure to APDN-US. Comparing the performance and risk of Applied DNA Sciences, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)

  • Applied DNA Sciences, Inc. :APDN-US: Earnings Analysis: Q3, 2017 By the Numbers : September 8, 2017
    Capital Cubelast month

    Applied DNA Sciences, Inc. :APDN-US: Earnings Analysis: Q3, 2017 By the Numbers : September 8, 2017

    Categories: Yahoo FinanceGet free summary analysis Applied DNA Sciences, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Applied DNA Sciences, Inc. – Sensient Technologies Corporation, Cabot Corporation and Huntsman Corporation (SXT-US, CBT-US and HUN-US) that have also reported for this period. Highlights Summary numbers: ... Read more (Read more...)

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of APDN earnings conference call or presentation 10-Aug-17 8:30pm GMT

    Q3 2017 Applied DNA Sciences Inc Earnings Call

  • Associated Press2 months ago

    Applied DNA Sciences reports 3Q loss

    The Stony Brook, New York-based company said it had a loss of 10 cents per share. The DNA-based security technology company posted revenue of $1.8 million in the period. In the final minutes of trading ...

  • Zacks Small Cap Research4 months ago

    Update on APDN 2017 Fiscal Second Quarter Financials

    Recently, Applied DNA Sciences (APDN) announced financial results for the fiscal second quarter ended March 31, 2017. Total revenue for the fiscal second quarter was $0.91 million, compared with $0.57 million reported in the same period for fiscal 2016, an increase of 58%. The year-over-year increase in total revenue was primarily attributable to an increase in textile revenues and to a lesser extent, an increase in sales of consumer asset marking products.

  • Capital Cube4 months ago

    ETFs with exposure to Applied DNA Sciences, Inc. : June 5, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Applied DNA Sciences, Inc. Here are 5 ETFs with the largest exposure to APDN-US. Comparing the performance and risk of Applied DNA Sciences, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)

  • Applied DNA Sciences, Inc. :APDN-US: Earnings Analysis: Q2, 2017 By the Numbers : June 2, 2017
    Capital Cube5 months ago

    Applied DNA Sciences, Inc. :APDN-US: Earnings Analysis: Q2, 2017 By the Numbers : June 2, 2017

    Categories: Yahoo FinanceGet free summary analysis Applied DNA Sciences, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Applied DNA Sciences, Inc. – Huntsman Corporation, Sensient Technologies Corporation, Cabot Corporation and Electronics For Imaging, Inc. (HUN-US, SXT-US, CBT-US and EFII-US) that have also reported for ... Read more (Read more...)

  • Associated Press5 months ago

    Applied DNA Sciences reports 2Q loss

    The Stony Brook, New York-based company said it had a loss of 13 cents per share. The DNA-based security technology company posted revenue of $905,373 in the period. Its adjusted revenue was $905,000. ...

  • Capital Cube6 months ago

    ETFs with exposure to Applied DNA Sciences, Inc. : April 26, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Applied DNA Sciences, Inc. Here are 5 ETFs with the largest exposure to APDN-US. Comparing the performance and risk of Applied DNA Sciences, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)

  • Capital Cube6 months ago

    ETFs with exposure to Applied DNA Sciences, Inc. : April 7, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Applied DNA Sciences, Inc. Here are 5 ETFs with the largest exposure to APDN-US. Comparing the performance and risk of Applied DNA Sciences, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)

  • Applied DNA Sciences, Inc. :APDN-US: Earnings Analysis: Q1, 2017 By the Numbers : March 20, 2017
    Capital Cube7 months ago

    Applied DNA Sciences, Inc. :APDN-US: Earnings Analysis: Q1, 2017 By the Numbers : March 20, 2017

    Categories: Yahoo Finance Get free summary analysis Applied DNA Sciences, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Applied DNA Sciences, Inc. – Huntsman Corporation, Sensient Technologies Corporation, Cabot Corporation and Electronics For Imaging, Inc. (HUN-US, SXT-US, CBT-US and EFII-US) that have also reported for ... Read more (Read more...)

  • Zacks Small Cap Research8 months ago

    APDN: An DNA solution for product authentication

    Total revenue for the fiscal first quarter was $0.9 million, compared with $1.32 million reported in the first quarter of fiscal 2016, a decrease of 32%. Total revenue for 1Q17 also decreased 45% from the $1.64 million reported in the fourth fiscal quarter ended September 30, 2016.

  • Associated Press8 months ago

    Applied DNA Sciences reports 1Q loss

    The Stony Brook, New York-based company said it had a loss of 16 cents per share. The DNA-based security technology company posted revenue of $903,000 in the period. In the final minutes of trading on ...

  • Capital Cube9 months ago

    ETFs with exposure to Applied DNA Sciences, Inc. : January 9, 2017

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Applied DNA Sciences, Inc. Here are 5 ETFs with the largest exposure to APDN-US. Comparing the performance and risk of Applied DNA Sciences, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)

  • Capital Cube10 months ago

    Applied DNA Sciences, Inc. :APDN-US: Earnings Analysis: 2016 By the Numbers : December 14, 2016

    Categories: Yahoo Finance Get free summary analysis Applied DNA Sciences, Inc. reports financial results for the year ended September 30, 2016. We analyze the earnings along side the following peers of Applied DNA Sciences, Inc. – Huntsman Corporation, Sensient Technologies Corporation, Cabot Corporation and Electronics For Imaging, Inc. (HUN-US, SXT-US, CBT-US and EFII-US) that have also reported for ... Read more (Read more...)

  • Thomson Reuters StreetEvents10 months ago

    Edited Transcript of APDN earnings conference call or presentation 6-Dec-16 9:30pm GMT

    Q4 2016 Applied DNA Sciences Inc Earnings Call

  • Zacks Small Cap Research10 months ago

    APDN: Update on Fiscal Fourth Quarter Financials

    On December 6, Applied DNA Sciences (APDN) announced financial results for the fiscal fourth quarter ended September 30, 2016. Total revenue for the fiscal fourth quarter of 2016 was $1.64 million, compared to $3.98 million for the same period of 2015, a decrease of 59%. During the conference call, management indicated that the year-over-year decrease in revenue resulted primarily from decreased sales to the textile industry for the securing of global cotton supply chains and reduced revenues from two non-recurring government commercialization contract awards that were completed in the fourth quarter of fiscal 2016.